Related Experiment Video
Updated: May 11, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Neonatal meningitis and sepsis by Chryseobacterium indologenes: a rare and resistant bacterium
Vandana Kalwaje Eshwara1, Arun Sasi, Frenil Munim
1Department of Microbiology, Kasturba Medical College, Manipal University, Manipal, Udupi, Karnataka, 576104, India, vandanake@gmail.com.
Abstract:
Early neonatal meningitis with non-fermenting Gram negative bacilli (NFGNB) is rare, and whenever it occurrs, inanimate environment is usually implicated as the source. The authors report a case of neonatal meningitis and sepsis with Chryseobacterium indologenes, a rare non fermenting Gram negative bacterium with unusual antimicrobial susceptibility. Despite resistance to all the beta lactams, carbapenems and aminoglycosides, therapy with ciprofloxacin led to a favorable outcome.
Insights
Early neonatal meningitis caused by rare bacteria is uncommon. Ciprofloxacin effectively treated a case of Chryseobacterium indologenes meningitis and sepsis, despite the pathogen
Area of Science:
- Neonatal infectious diseases
- Clinical microbiology
- Antimicrobial resistance
Background:
- Early neonatal meningitis is rare, often linked to environmental sources.
- Non-fermenting Gram-negative bacilli (NFGNB) are infrequent causes of neonatal meningitis.
- Chryseobacterium indologenes is a rare NFGNB with unusual antimicrobial resistance patterns.
Observation:
- A case of neonatal meningitis and sepsis caused by Chryseobacterium indologenes is presented.
- The bacterium exhibited resistance to beta-lactams, carbapenems, and aminoglycosides.
- The clinical presentation and microbiological findings are detailed.
Findings:
- Successful treatment of Chryseobacterium indologenes meningitis and sepsis was achieved with ciprofloxacin.
- This outcome is notable given the bacterium's resistance to multiple standard antibiotic classes.
- Ciprofloxacin demonstrated efficacy against this rare pathogen in a neonatal setting.
Implications:
- Highlights the potential for ciprofloxacin in treating infections caused by multidrug-resistant NFGNB.
- Suggests the need for broader antimicrobial susceptibility testing and consideration of alternative agents.
- Informs clinical management strategies for rare bacterial meningitis in neonates.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Bacterial Phylum Chlamydiae
Bacterial Phylum Spirochaetes
Encephalitis l: Introduction

